Tech Company Financing Transactions
ResApp Health Funding Round
ResApp Health, based in Brisbane QLD, raised $12.5 million from private investors.
Transaction Overview
Company Name
Announced On
4/22/2016
Transaction Type
Venture Equity
Amount
$12,500,000
Round
Undisclosed
Investors
private investors (Lead Investor) (Udantha Abeyratne)
Proceeds Purpose
According to a company release, the proceeds from the placement will be used to: Expedite US FDA approval for the adult diagnostic test by accelerating US clinical studies in adults. Expand US market access beyond telehealth into in-clinic use, including in emergency department and outpatient settings. Accelerate development of tools for managing chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Globally, asthma affects as many as 334 million people and COPD affects 65 million people.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
100 Creek St. Level 12
Brisbane QLD, 4000
Australia
Brisbane QLD, 4000
Australia
Phone
Website
Email Address
Overview
ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. We are creating easy to use, affordable, clinically-validated and regulatory-approved diagnostic tools that only require a smartphone.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/22/2016: CareerFoundry venture capital transaction
Next: 4/22/2016: Anomali venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs